Inventor
WOODWARD DAVID F
US108 patents
⚠️ This page may combine multiple inventors who share the name “WOODWARD DAVID F”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALLERGAN INC
38 patentsUS5688819ANov 18, 1997
Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
ALLERGAN INC309 citations99
US5352708AOct 4, 1994
Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
ALLERGAN INC195 citations99
US5034413AJul 23, 1991
Intraocular pressure reducing 9,11-diacyl prostaglandins
ALLERGAN INC304 citations99
US5028624AJul 2, 1991
Intraocular pressure reducing 9,15-diacyl prostaglandins
ALLERGAN INC155 citations99
US4994274AFeb 19, 1991
Intraocular pressure reducing 11,15-diacyl prostaglandins and method of using
ALLERGAN INC160 citations99
US7351404B2Apr 1, 2008
Method of enhancing hair growth
ALLERGAN INC83 citations98
US5607978AMar 4, 1997
Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
ALLERGAN INC117 citations98
US5698598ADec 16, 1997
EP2 -receptor agonists as agents for lowering intraocular pressure
ALLERGAN INC76 citations96
US5462968AOct 31, 1995
EP2 -receptor agonists as agents for lowering intraocular pressure
ALLERGAN INC59 citations96
US5446041AAug 29, 1995
Intraocular pressure reducing 11-acyl prostaglandins
ALLERGAN INC100 citations96
US8038988B2Oct 18, 2011
Method of enhancing hair growth
ALLERGAN INC39 citations95
US8017655B2Sep 13, 2011
Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
ALLERGAN INC24 citations93
US7868035B2Jan 11, 2011
Therapeutic esters
ALLERGAN INC22 citations93
US5877211AMar 2, 1999
EP2 receptor agonists as neuroprotective agents for the eye
ALLERGAN INC51 citations93
US7491383B2Feb 17, 2009
Compositions having enhanced pharmacokinetic characteristics
ALLERGAN INC56 citations92
US6956057B2Oct 18, 2005
EP4 agonists as agents for lowering intraocular pressure
ALLERGAN INC16 citations92
US5476872ADec 19, 1995
1,11-diesters of prostaglandin-F2α having a polar ester group at C-1
ALLERGAN INC22 citations92
US5288754AFeb 22, 1994
Polar C-1 esters of prostaglandins
ALLERGAN INC47 citations92
US5238961AAug 24, 1993
Pgf 1-alcohols and their use as ocular hypotensives
ALLERGAN INC23 citations92
US10045997B2Aug 14, 2018
Hypotensive lipid and timolol compositions and methods of using same
ALLERGAN INC11 citations91
US5521183AMay 28, 1996
Use of 5-HT ligands as anti-pruritic agents
ALLERGAN INC26 citations86
US6713268B2Mar 30, 2004
Methods of identifying ocular hypotensive compounds having reduced hyperpigmentation
ALLERGAN INC23 citations85
US9700503B2Jul 11, 2017
Composition of enhancing hair growth
ALLERGAN INC13 citations84
US7045634B2May 16, 2006
Prostamide receptor antagonists
ALLERGAN INC12 citations84
US9889142B2Feb 13, 2018
Prostamide-containing intraocular implant
ALLERGAN INC7 citations83
US9289413B2Mar 22, 2016
Prostamide-containing intraocular implant
ALLERGAN INC13 citations83
US8926953B2Jan 6, 2015
Method of enhancing hair growth
ALLERGAN INC5 citations83
US8906907B2Dec 9, 2014
Hypotensive lipid and timolol compositions and methods of using same
ALLERGAN INC6 citations83
US7198928B2Apr 3, 2007
Human COX-1 alternatively spliced variants and methods of using same
ALLERGAN INC11 citations83
US5369127ANov 29, 1994
1,3-benzodioxole and 1,2-dialkoxybenzene derivatives as ocular hypotensive agents
ALLERGAN INC11 citations82
US5814657ASep 29, 1998
1,3-benzodioxole and 1,2-dialkoxybenzene derivatives as ocular hypotensive agents
ALLERGAN INC5 citations74
US5741812AApr 21, 1998
Thromboxane ligands without blood clotting side effects
ALLERGAN INC9 citations74
US5661178AAug 26, 1997
Method for effecting vasodilation with (1,5-inter)aryl prostaglandin derivatives
ALLERGAN INC11 citations74
US5574066ANov 12, 1996
Intraocular pressure reducing 15-acyl prostaglandins
ALLERGAN INC12 citations74
US5516791AMay 14, 1996
7-[carboxyakyl or alkenyl]-6-[alkyl or alkenyl]3-oxo-2,4-dioxobicyclo-[3.2.1]octane and derivatives thereof
ALLERGAN INC8 citations74
US5416106AMay 16, 1995
7-[carboxyalkyl or alkenyl]-6-[alkyl or alkenyl]3-oxo-2,4-dioxobicyclo-[3.2.1] octane and derivatives thereof
ALLERGAN INC8 citations74
US5270049ADec 14, 1993
2-decarboxyl-2-aminoalkyl-prostaglandins as ocular hypotensives
ALLERGAN INC12 citations74
US8986715B2Mar 24, 2015
Method of enhancing hair growth
ALLERGAN INC2 citations73
WOODWARD DAVID F
5 patentsUS8101161B2Jan 24, 2012
Method of enhancing hair growth
WOODWARD DAVID F27 citations95
US8298518B2Oct 30, 2012
Method of enhancing hair growth
WOODWARD DAVID F8 citations92
US8263054B2Sep 11, 2012
Method of enhancing hair growth
WOODWARD DAVID F18 citations92
US8632760B2Jan 21, 2014
Method of enhancing hair growth
WOODWARD DAVID F6 citations83
US8648213B2Feb 11, 2014
Prostamides for the treatment of glaucoma and related diseases
WOODWARD DAVID F4 citations73
ALLERGAN SALES INC
4 patentsUS6403649B1Jun 11, 2002
Non-acidic cyclopentane heptanoic acid,2-cycloalkyl or arylalkyl derivatives as therapeutic agents
ALLERGAN SALES INC272 citations99
US6090847AJul 18, 2000
EP2 -receptor agonists as neuroprotective agents for the eye
ALLERGAN SALES INC51 citations93
US6258844B1Jul 10, 2001
Cyclopentane (ene) oic acid, 2-alkenyl derivatives as therapeutic agents
ALLERGAN SALES INC20 citations92
US6395787B1May 28, 2002
Ocular hypotensive lipids
ALLERGAN SALES INC51 citations89
CHEN JUNE
2 patentsCARLING WILLIAM R
1 patentShowing the top 50 of 108 patents by PatentIndex Score.